Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
Top Cited Papers
- 1 June 2000
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (6) , 685-708
- https://doi.org/10.1016/s0149-2918(00)90004-3
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- StavudineDrugs, 1999
- Adefovir DipivoxilDrugs, 1999
- Mitochondrial sensitivity to AZTCell Biochemistry and Function, 1998
- Peripheral Neuropathy with Nucleoside AntiretroviralsDrug Safety, 1998
- Lack of mitochondrial toxicity in CEM cells treated with carbovirAntiviral Research, 1997
- DidanosineDrugs, 1996
- Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivativesInternational Journal of Clinical Pharmacy, 1994
- AZT Causes Tissue-Specific Inhibition of Mitochondrial Bioenergetic FunctionBiochemical and Biophysical Research Communications, 1993
- Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidineBiochemical and Biophysical Research Communications, 1991
- Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerasesBiochemical and Biophysical Research Communications, 1989